Baseline patient characteristics
| Characteristic . | No. of patients (%) . |
|---|---|
| Age, y | |
| Median | 68 y |
| Range | 22-85 y |
| > 60 y | 49 (77) |
| Male | 44 (69) |
| Stage | |
| Bulky II | 5 (8) |
| III | 31 (48) |
| IV | 28 (44) |
| Elevated LDH | 48 (75) |
| Performance Status | |
| 0 | 26 (41) |
| 1 | 33 (52) |
| 2 | 5 (8) |
| IPI risk factors | |
| 0 or 1 | 4 (6) |
| 2 | 22 (34) |
| 3 | 29 (45) |
| 4 or 5 | 9 (14) |
| Characteristic . | No. of patients (%) . |
|---|---|
| Age, y | |
| Median | 68 y |
| Range | 22-85 y |
| > 60 y | 49 (77) |
| Male | 44 (69) |
| Stage | |
| Bulky II | 5 (8) |
| III | 31 (48) |
| IV | 28 (44) |
| Elevated LDH | 48 (75) |
| Performance Status | |
| 0 | 26 (41) |
| 1 | 33 (52) |
| 2 | 5 (8) |
| IPI risk factors | |
| 0 or 1 | 4 (6) |
| 2 | 22 (34) |
| 3 | 29 (45) |
| 4 or 5 | 9 (14) |
LDH indicates lactate dehydrogenase.